- Home
- BMRA vs QNTM Comparison
BMRA vs QNTM Comparison
Compare BMRA & QNTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRA
- QNTM
- Stock Information
- Founded
- BMRA 1971
- QNTM 1998
- Country
- BMRA United States
- QNTM Canada
- Employees
- BMRA N/A
- QNTM N/A
- Industry
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- QNTM
- Sector
- BMRA Health Care
- QNTM
- Exchange
- BMRA Nasdaq
- QNTM NYSE
- Market Cap
- BMRA 9.2M
- QNTM 8.7M
- IPO Year
- BMRA N/A
- QNTM N/A
- Fundamental
- Price
- BMRA $3.67
- QNTM $9.15
- Analyst Decision
- BMRA
- QNTM
- Analyst Count
- BMRA 0
- QNTM 0
- Target Price
- BMRA N/A
- QNTM N/A
- AVG Volume (30 Days)
- BMRA 48.3K
- QNTM 101.1K
- Earning Date
- BMRA 04-14-2025
- QNTM 05-06-2025
- Dividend Yield
- BMRA N/A
- QNTM N/A
- EPS Growth
- BMRA N/A
- QNTM N/A
- EPS
- BMRA N/A
- QNTM N/A
- Revenue
- BMRA $5,678,000.00
- QNTM N/A
- Revenue This Year
- BMRA N/A
- QNTM N/A
- Revenue Next Year
- BMRA N/A
- QNTM N/A
- P/E Ratio
- BMRA N/A
- QNTM N/A
- Revenue Growth
- BMRA 5.01
- QNTM N/A
- 52 Week Low
- BMRA $1.92
- QNTM $2.70
- 52 Week High
- BMRA $10.16
- QNTM $25.35
- Technical
- Relative Strength Index (RSI)
- BMRA 46.61
- QNTM 62.27
- Support Level
- BMRA $3.41
- QNTM $7.96
- Resistance Level
- BMRA $3.74
- QNTM $9.45
- Average True Range (ATR)
- BMRA 0.30
- QNTM 0.72
- MACD
- BMRA 0.05
- QNTM 0.10
- Stochastic Oscillator
- BMRA 43.29
- QNTM 90.00
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
About QNTM QUANTUM BIOPHARMA LTD
Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.